Modulation of Cerebral Ischemia by Albumin
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.
Also called NCT07415655
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 100 participants
- Registry
-
NCT07415655
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Czechia
- Registry status
- Recruiting
Technical summary
Registry record NCT07415655. Randomized; no masking; primary purpose treatment. Start 2026-02-03 (actual); primary completion 2027-02-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Modulation of Cerebral Ischemia by Albumin
- Acronym
- MOZEG
- Condition
- Ischemic Stroke
- Intervention (Drug)
- Albumin infusion
- Intervention (Drug)
- Placebo Injection
- Lead sponsor
- University Hospital Hradec Kralove
Record details
- Record id
cardio:ct-nct07415655- Content hash
777a33e57085aaaed8454f5ef6b563c2fea297faefd9e69aab4ef72a45361bde